The Russian pharmaceutical company "Geropharm" has created and registered insulin "Ringluzin". This was reported in the company's press service.
The new drug is the first Russian analogue of the French insulin "Apidra".
"Geropharm" registered a new insulin "Ringluzin" with the active substance glulisine, which is equal in strength to ordinary human insulin.
"Ringluzin" will be produced from the substance to the finished drug according to the principle of a full cycle at the Geropharm plants in the Moscow region and St. Petersburg. The volume of production will be determined based on demand.
Earlier www1.ru reported that new antibiotics will appear in Russia.
Read materials on the topic:
Stavropol scientists have developed nanoparticles to increase the effectiveness of antibiotics
First in the world: a gel for bone regeneration after gunshot wounds was invented in Russia
Russia has developed drugs for spinal muscular atrophy and Bekhterev's disease